Evidence map›Paper›PMID 36014695›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Natural Diatomite Supported Zirconium-Doped TiO

Fang Yuan, Chunquan Li, Xiangwei Zhang, Renfeng Yang, Zhiming Sun

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fang YuanSchool of Chemical and Environmental Engineering, China University of Mining and Technology (Beijing), Beijing 100083, China.
Chunquan LiSchool of Chemical and Environmental Engineering, China University of Mining and Technology (Beijing), Beijing 100083, China.ORCID 0000-0002-4503-1244
Xiangwei ZhangSchool of Chemical and Environmental Engineering, China University of Mining and Technology (Beijing), Beijing 100083, China.
Renfeng YangSchool of Chemical and Environmental Engineering, China University of Mining and Technology (Beijing), Beijing 100083, China.
Zhiming SunSchool of Chemical and Environmental Engineering, China University of Mining and Technology (Beijing), Beijing 100083, China.ORCID 0000-0001-9818-1994
China University of Mining and Technology · CN

Funding

Fok Ying Tung Foundation 171042
6 · The paper itself

Abstract

The development of economically applicable, highly efficient and low cost photocatalytic materials has always been a challenge. In this work, we report a zirconium doped TiO2/diatomite (ZrTD) composite with enhanced visible light-induced photocatalytic activity. The as-prepared samples were characterized by X-ray diffraction, scanning electron microscopy, UV-VIS diffused reflectance spectroscopy, high-performance liquid chromatography-mass spectrometry, photoluminescence and X-ray photoelectron spectroscopy, respectively. The optimal doping ratio of zirconium into TiO2 was obtained at 3% (3%ZrTD composite), and the degradation rate constant of which tetracycline (TC) is up to around 8.65 times higher that of zirconium doped TiO2. In addition, zirconium doping introduces the impurity levels of Zr 3d and oxygen vacancies into the lattice of TiO2, resulting in broadening the light absorption range, reducing the band gap, and improving the separation efficiency of photogenerated electron-hole pairs, thus endowing with visible light photocatalytic properties. Moreover, both the photogenerated holes (h+) and superoxide (•O2-) radicals are responsible for the degradation process of TC, and a possible degradation pathway and the corresponding intermediate products of TC by ZrTD composite are also proposed in detail.

Indexed as

diatomitetetracyclineTiO2visible light photocatalysisZr-doped

Identifiers

PMID36014695
PMCPMC9413476
OpenAlexW4292261400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.